Sandoz Inc. 2019-08-29 Health safe CPSC
Health · CPSC · Recall #CPSC-19194
Losartan Potassium and Ezetimibe prescription drug bottles Recall
Issued August 29, 2019 · Sandoz Inc. · 636,000 units affected
In August 2019, Sandoz Inc. recalled the Losartan Potassium and Ezetimibe prescription drug bottles, a low-risk health recall reported by the CPSC. Affected owners are eligible for a replace. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.
What you should do
- 1 Stop using Losartan Potassium and Ezetimibe prescription drug bottles right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Sandoz Inc. to arrange your replace. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Replace): Consumers should immediately secure the medications to keep them out of the sight and reach of children and contact Sandoz for a free replacement child resistant bottle cap. Once the medication is secured, consumers can continue to use the medication as directed.
Recall details
- Brand
- Sandoz Inc.
- Category
- Health
- Recall date
- August 29, 2019
- Units affected
- 636,000
- Sold at
- Clinics and pharmacies nationwide as a prescribed medicine from July 2018 through August 2019. The container was included in the price of the medication, which varied based on quantities prescribed, health insurance terms and other factors.
- Recall number
- CPSC-19194
- Made in
- Slovenia
- Issuing agency
- CPSC
In context
- Sandoz Inc. has 2 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- 636,000 units is enough to reach roughly 1 in every 206 US households.
- This is the 7th Health recall we've logged in 2019.